S8 Ep36: FDA Approval Insights: Dostarlimab in dMMR Advanced Endometrial Cancer
Dr Gilbert discusses the FDA approval of dostarlimab in patients with endometrial cancer, key efficacy data from the GARNET trial, and how this agent bolsters the endometrial cancer treatment paradigm.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.